He completed his hematology and oncology training at the National Heart Lung Blood Institute in NIH. Dr. Gustavo Rivero, MD is board certified in Internal Medicine and Hematology. His area of expertise includes hematological and lymphoid malignancies. Dr. Rivero has special interest in drug development design for myelodysplastic syndrome and acute myelogenous leukemia. In addition, he actively participates in research intended to improve understanding of mechanisms of leukemogenesis and marrow failure associated with MDS.